Asked by: Harriet Cross (Conservative - Gordon and Buchan)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Human Fertilisation and Embryology Authority on the proposal for it to be designated as the regulator for surrogacy, as recommended in the Law Commission’s report Building Families Through Surrogacy: A New Law.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health will be writing to the Chairs of the Law Commissions of England, Wales, and Scotland shortly, to follow up their meeting on 5 November. A Government response to the commission’s report will be published as time allows.
The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health met with the Human Fertilisation and Embryology Authority senior team on 20 July 2024. Regulatory oversight of surrogacy was discussed as part of a broader introductory discussion.
Asked by: Harriet Cross (Conservative - Gordon and Buchan)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when the Government plans to publish its full response to the Law Commission’s report Building Families Through Surrogacy: A New Law, published in March 2023, following its interim response on 8 November 2023.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health will be writing to the Chairs of the Law Commissions of England, Wales, and Scotland shortly, to follow up their meeting on 5 November. A Government response to the commission’s report will be published as time allows.
The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health met with the Human Fertilisation and Embryology Authority senior team on 20 July 2024. Regulatory oversight of surrogacy was discussed as part of a broader introductory discussion.
Asked by: Harriet Cross (Conservative - Gordon and Buchan)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of developing a dedicated national brain tumour strategy within the Major Conditions Strategy framework to help improve (a) early diagnosis rates, (b) research funding allocation, (c) access to Clinical Nurse Specialists and (d) treatment outcomes for patients with brain tumours.
Answered by Andrew Gwynne
Plans to publish a final major conditions strategy were paused following the announcement of the general election. We are developing a 10-year plan to radically reform the National Health Service, and My Rt Hon. Friend, the Secretary of State for Health and Social Care has been clear that there needs to be a national cancer plan, which will include brain cancer. We are currently in discussions about this plan and its relationship to the 10-Year Health Plan and the Government’s wider health mission.
To improve early diagnosis rates for brain cancer, we have expanded general practice direct access to diagnostic scans, including brain magnetic resonance imaging.
In September 2024, the Government announced new research opportunities, including a National Institute for Health Care and Research Brain Tumour Research Consortium and a funding call to generate high quality evidence in brain tumour care, support, and rehabilitation.
To improve outcomes, NHS England is committed to ensuring that all cancer patients are offered Holistic Needs Assessment and Personalised Care and Support Planning, ensuring care is focused on what matters most to each person. As well as this, all patients, including those with secondary cancers, will have access to the right expertise and support, including a Clinical Nurse Specialist or other support worker.
Asked by: Harriet Cross (Conservative - Gordon and Buchan)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of current shortages in the supply of Salbutamol nebules on patients with respiratory conditions; and what steps his Department is taking to tackle procurement and supply chain issues to ensure continuity of supply.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Supply of salbutamol nebules, used to treat asthma, has now improved, although there may still be some short intermittent interruptions in supply experienced. We are working with NHS England to manage the supply issues and mitigate risks to patients. Communications have been issued to the National Health Service to provide management advice for all pharmacy teams and prescribers with information on alternative treatments that are available.